EyePACS LLC a privately held company and the leading diabetic retinopathy telemedicine provider in the US, announces that, in February of this year, it has surpassed 5 million retinal images in its global comprehensive retinal diagnostic and study database.

Beginning in 2003 with its first deployment in California, the EyePACS comprehensive retina diagnostic and study platform has been used by certified and credentialed eye clinicians to provide retinal assessment for nearly 1 million diabetic patients.  Deployed in more than 600 community health centers across the US and additional sites internationally, the EyePACS telemedicine platform is the largest assessment network of its kind for diabetic retinopathy.